• Cholesterylester Transfe
  • Cholesterylester Transfer Protein (CETP) Inhibitor - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cholesterylester Transfer Protein (CETP) Inhibitor development. (reportbuyer.com)
  • Descriptive coverage of pipeline development activities for "Cholesterylester Transfer Protein (CETP) Inhibitor - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. (reportbuyer.com)
  • The report assesses the active Cholesterylester Transfer Protein (CETP) Inhibitor pipeline products by developmental stage, product type, molecule type, and administration route. (reportbuyer.com)
  • Offers detailed therapeutic product profiles of Cholesterylester Transfer Protein (CETP) Inhibitor with key coverage of developmental activities including licensing & collaboration deals, patent details. (reportbuyer.com)
  • studies
  • A three-dimensional structure of tetrahydroquinoxaline inhibitor 6 was proposed from 1 H NMR structural studies, and this model was then used in silico for the design of a new class of compounds based upon an indoline scaffold. (newdrugapprovals.org)